Profile data is unavailable for this security.
About the company
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
- Revenue in USD (TTM)64.74m
- Net income in USD-42.11m
- Incorporated2012
- Employees227.00
- LocationTELA Bio Inc1 Great Valley Parkway, Suite 24MALVERN 19355United StatesUSA
- Phone+1 (484) 320-2930
- Fax+1 (302) 655-5049
- Websitehttp://www.telabio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LENSAR Inc | 45.12m | -12.56m | 81.77m | 130.00 | -- | 3.44 | -- | 1.81 | -1.11 | -1.11 | 3.92 | 3.24 | 0.6806 | 1.25 | 9.08 | 347,107.70 | -18.94 | -30.97 | -22.49 | -36.94 | 49.87 | 51.04 | -27.83 | -52.30 | 2.15 | -- | 0.00 | -- | 19.25 | 11.57 | 27.77 | -- | -42.91 | -- |
| Owlet Inc | 65.64m | -15.92m | 82.65m | 76.00 | -- | -- | -- | 1.26 | -1.89 | -1.89 | 7.61 | -2.29 | 1.27 | 3.48 | 4.39 | 863,618.40 | -20.24 | -- | -165.32 | -- | 45.71 | -- | -15.91 | -- | 0.8168 | -40.50 | -- | -- | -21.95 | -- | 52.74 | -- | -- | -- |
| Edap Tms SA (ADR) | 65.91m | -20.89m | 97.95m | 307.00 | -- | 1.94 | -- | 1.49 | -0.5634 | -0.5634 | 1.78 | 1.36 | 0.6992 | 2.37 | 3.42 | 214,706.50 | -22.16 | -6.62 | -31.50 | -9.22 | 40.34 | 43.23 | -31.69 | -9.59 | 1.80 | -- | 0.0599 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Harvard Bioscience, Inc. | 101.13m | -10.68m | 99.43m | 391.00 | -- | 1.48 | -- | 0.9833 | -0.2471 | -0.2471 | 2.35 | 1.54 | 0.7441 | 1.64 | 6.88 | 258,631.70 | -7.86 | -3.29 | -9.44 | -3.89 | 58.39 | 56.67 | -10.56 | -4.57 | 0.9416 | -1.31 | 0.3467 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| 908 Devices Inc. | 52.69m | -37.99m | 101.20m | 230.00 | -- | 0.6467 | -- | 1.92 | -1.15 | -1.15 | 1.60 | 4.52 | 0.2511 | 1.54 | 4.95 | 229,069.60 | -18.11 | -14.16 | -20.12 | -15.35 | 52.32 | 53.02 | -72.10 | -64.25 | 4.23 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| Fonar Corp | 102.89m | 9.91m | 103.61m | 520.00 | 10.74 | 0.6243 | 4.60 | 1.01 | 1.44 | 1.44 | 15.02 | 24.73 | 0.496 | 21.85 | 1.37 | 197,855.90 | 6.80 | 7.30 | 7.09 | 7.87 | 43.87 | 47.13 | 13.70 | 14.50 | 7.71 | -- | 0.0047 | -- | 4.30 | 3.36 | 12.58 | -7.16 | -25.07 | -- |
| Sensus Healthcare Inc | 36.37m | 6.65m | 117.18m | 35.00 | 17.56 | 2.22 | 17.07 | 3.22 | 0.4072 | 0.4072 | 2.23 | 3.23 | 0.6601 | 1.10 | 2.65 | 1,039,057.00 | 12.06 | 10.29 | 13.25 | 12.14 | 60.23 | 62.85 | 18.27 | 15.29 | 8.20 | -- | 0.00 | -- | -45.20 | -1.58 | -98.00 | -- | -23.16 | -- |
| TELA Bio Inc | 64.74m | -42.11m | 122.50m | 227.00 | -- | 26.74 | -- | 1.89 | -1.71 | -1.71 | 2.64 | 0.1163 | 0.8376 | 1.48 | 7.62 | 285,215.80 | -54.48 | -52.00 | -66.54 | -60.95 | 68.61 | 65.32 | -65.04 | -107.65 | 2.52 | -8.69 | 0.9343 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| KORU Medical Systems Inc | 30.82m | -11.76m | 136.19m | 82.00 | -- | 7.28 | -- | 4.42 | -0.2574 | -0.2574 | 0.6742 | 0.4082 | 0.9737 | 2.94 | 6.50 | 375,817.30 | -37.15 | -17.60 | -43.48 | -20.29 | 62.49 | 59.44 | -38.16 | -21.70 | 3.27 | -- | 0.0195 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| EUDA Health Holdings Ltd | 3.81m | -17.99m | 140.16m | 106.00 | -- | -- | -- | 36.77 | -0.4821 | -0.4451 | 0.1487 | -0.1685 | 1.86 | -- | 7.21 | 35,957.55 | -876.41 | -- | -- | -- | 22.05 | -- | -472.08 | -- | -- | -43.68 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| Myomo Inc | 25.24m | -8.38m | 150.93m | 101.00 | -- | 16.24 | -- | 5.98 | -0.2294 | -0.2294 | 0.6847 | 0.3072 | 1.51 | 3.11 | 8.08 | 249,892.40 | -50.25 | -81.78 | -81.40 | -115.27 | 70.03 | 68.50 | -33.22 | -85.76 | 1.62 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Acme United Corp | 190.49m | 19.52m | 156.32m | 645.00 | 8.46 | 1.45 | 7.25 | 0.8206 | 4.94 | 4.94 | 46.90 | 28.77 | 1.18 | 2.09 | 5.84 | 295,331.70 | 12.13 | 7.09 | 14.25 | 8.29 | 39.37 | 35.72 | 10.25 | 5.50 | 1.91 | 7.06 | 0.2337 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
| Cibus Inc | 4.15m | -445.40m | 156.87m | 183.00 | -- | 1.30 | -- | 37.77 | -22.43 | -22.43 | 0.1987 | 4.09 | 0.0071 | -- | 4.75 | 22,693.99 | -91.76 | -86.28 | -109.53 | -96.45 | -- | -- | -12,860.99 | -792.07 | -- | -3.23 | 0.0061 | -- | 1,057.33 | 50.41 | -1,484.44 | -- | 18.53 | -- |
| Akoya Biosciences Inc | 93.22m | -60.35m | 157.90m | 330.00 | -- | 7.09 | -- | 1.69 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Alpha Tau Medical Ltd | 0.00 | -27.63m | 158.03m | 121.00 | -- | 2.14 | -- | -- | -0.3966 | -0.3966 | 0.00 | 1.06 | 0.00 | -- | -- | 0.00 | -26.66 | -- | -28.28 | -- | -- | -- | -- | -- | -- | -- | 0.0681 | -- | -- | -- | 13.64 | -- | -- | -- |
| Pro-Dex Inc | 56.80m | 5.21m | 161.50m | 148.00 | 32.38 | 5.29 | 25.28 | 2.84 | 1.53 | 1.53 | 16.34 | 9.36 | 1.09 | 2.48 | 4.64 | 383,770.30 | 10.03 | 12.33 | 12.35 | 15.30 | 28.25 | 31.26 | 9.17 | 12.13 | 1.94 | 5.31 | 0.304 | 0.00 | 16.83 | 14.66 | -69.93 | -12.47 | -6.80 | -- |
Data as of Nov 13 2024. Currency figures normalised to TELA Bio Inc's reporting currency: US Dollar USD
54.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Stonepine Capital Management LLCas of 23 Oct 2024 | 2.83m | 11.46% |
| Nantahala Capital Management LLCas of 30 Jun 2024 | 2.45m | 9.90% |
| AIGH Capital Management LLCas of 30 Jun 2024 | 1.66m | 6.70% |
| Grow Funds LLCas of 24 Jul 2024 | 1.40m | 5.67% |
| Paradigm Capital Management, Inc.as of 30 Jun 2024 | 1.26m | 5.08% |
| SilverArc Capital Management LLCas of 30 Jun 2024 | 1.00m | 4.05% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 898.90k | 3.64% |
| Velan Capital Investment Management LPas of 30 Jun 2024 | 746.09k | 3.02% |
| Federated Global Investment Management Corp.as of 30 Jun 2024 | 712.30k | 2.88% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 478.71k | 1.94% |
More ▼
Data from 30 Jun 2024 - 24 Jul 2024Source: FactSet Research Systems Inc.
